Full results from the Phase 2 REGEN-007 study of rilparencel were recently presented as a late-breaking clinical trial at the American Society of Nephrology (ASN) Kidney Week 2025More than half of the ...

A prespecified analysis of the SURPASS-CVOT trial assessed the efficacy and safety of tirzepatide compared with dulaglutide on kidney outcomes in patients with very high-risk CKD and type 2 diabetes.

Vivoryon Therapeutics N.V. Presents Phase 2 Kidney Function and Biomarker Data at the American Society of Nephrology Kidney Week 2025 ...

In patients with advanced chronic kidney disease (CKD) and diabetes, treatment with rilparencel resulted in statistically ...

Shares of Eledon Pharmaceuticals Inc. (NASDAQ: ELDN) were trading at $1.65, down $2.45, or 59%, after the company disclosed phase II results from the Bestow trial testing tegoprubart, which targets ...

Purespring co-author paper with real world evidence on epidemiological prevalence data of NPHS2 pathogenic variants across global populations London – 4 November 2025 – Purespring Therapeutics, a ...

Our kidneys are one of the most important organs of the body, that performs many key functions! Apart from filtering blood, kidneys also help in fluid elimination, and remove waste. Over time, our ...

Please provide your email address to receive an email when new articles are posted on . Hydroxychloroquine was associated with improved kidney function for patients with lupus nephritis. Patients and ...

Veteran actor Satish Shah passed away at 74. His death from kidney failure has raised awareness about kidney health. His passing due to kidney failure has once again highlighted the importance of ...

A recent scientific breakthrough has seen lab-grown kidneys successfully functioning in a human trial. This promising development has far-reaching implications for organ transplant procedures and the ...

Former Bihar chief minister Lalu Prasad Yadav has been dealing with a lot of health issues for some time now, and one of the issues is his state of kidney which is drawing particular attention and is ...

The FDA has approved Gazyva (obinutuzumab) for treating adult patients with active lupus nephritis who are already on ...